Outcomes Comparison of Intravenous Antimicrobials Provided in a Physician Office Infusion Center (POIC) versus Traditional Home Care (HC) Services

Richard C. Prokesch, MD, FACP, FIDSA,-Infectious Diseases Associates, P.C., Riverdale, GA
John S. Adams, MD – Knoxville Infectious Disease Consultants (KIDC), Knoxville, TN
Alfred E. Bacon III, MD – Infectious Disease Associates, PA, Newark, DE
Philip S. Brachman, MD – Atlanta Infectious Disease Group, Atlanta, GA
Lucinda J. Van Anglen – Healix Infusion Therapy, Inc, Sugar Land, TX

View Poster

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.